- Go to main content [shortcut key S], by skipping site tools, language selector, navigation path and navigation menu
- Go to navigation menu, by skipping site tools, language selector and navigation path
- Go to navigation path, by skipping site tools and language selector
- Go to language selector, by skipping site tools
- Go to site tools
![](/health/images/decorative/helping_reduce.jpg)
Scientific Hearing on Risk Assessment of Nanotechnologies
![logo](/health/images/logo.jpg)
Scientific Hearing on Risk Assessment of Nanotechnologies,
Brussels, 10 September 2009
Venue: Centre de Conference A. Borschette, Rue Froissart 36, 1040 Brussels
On 10 September 2009, the European Commission (DG Health and Consumers) is organising in Brussels a Scientific Hearing on the risk assessment of nanotechnologies.
The main objectives of this Hearing are to identify:
- any possible scientific topics which have not been covered in the opinions from the relevant EU Risk Assessment Committees and Bodies;
- what are -according to current scientific knowledge- the main potential risks that could emerge from the use of nanomaterials in the future; and
- provision of relevant background information and comments on those issues.
Draft Programme of the Scientific Hearing
Public consultation
Related events
Presentations
-
The Role of EU Scientific
Committees for Risk Assessment
of Nanomaterials
B. DELOGU,
Directorate-General for Health & Consumers, European Commission -
Public Consultation on Risk
Assessment of Nanotechnologies:
Summary of contributions
L. BONTOUX,
Directorate-General for Health & Consumers, European Commission -
(Scientific) Comments on the Public
Consultation’s Summary
W. H De JONG,
Vice Chair SCENIHR
| Top